The binding affinity of a ligand to a protein is influenced by the protonation and tautomeric states of both partners. However, this relationship remains under-investigated due to the limited availability of computational tools capable of treating charge and tautomer states together in a scalable manner to study clinic...
G. Ranepura, Saqibul I. Chowdhury, E. Rosenzweig et al.· Journal of Chemical Informat...· 0 citations
Structure-based drug discovery is a widely used paradigm for the rational design of novel small molecule therapeutics. However, the benefits conferred by the use of structural information has seen limited adoption in machine learning, where ligand-only ("2D") models are still the industry standard for molecular propert...
B. Kaminow, A. Payne, Hugo I. MacDermott-Opeskin et al.· bioRxiv· 0 citations
High-quality experimental datasets that link protein–ligand structures with binding affinity data are essential for developing and evaluating structure-based machine learning methods. To help address this need, we established OpenBind as an open-science initiative to generate large-scale experimental datasets for struc...
Jochem Nelen, Omeir Khan, Etowah Adams et al.· bioRxiv· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.